Water-soluble fluorescent probe as well as preparation method and application thereof

By designing water-soluble fluorescent probe compounds and zinc ion complexes, the problems of poor water solubility and insufficient biocompatibility of existing fluorescent probe materials are solved, and high selectivity and high sensitivity pyrophosphate ion recognition and bioimaging are achieved. Multifunctional application.

CN119080686APending Publication Date: 2024-12-06HENAN CHEM IND RES INST +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411093549.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-09
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The existing fluorescent probe materials have poor water solubility and poor biocompatibility, resulting in unsatisfactory detection results.

Method used

A water-soluble fluorescent probe compound was designed to recognize pyrophosphate ions through a specific group structure and a high selectivity and sensitivity of zinc ion complex, and prepared in the presence of a base by reacting it with a Pd(PPh3)4 catalyst.

Benefits of technology

The high selectivity and high sensitivity of fluorescent probes are achieved to recognize pyrophosphate ions, and combined with the characteristics of carrier materials, it improves the multifunctionalization and high performance of bioimaging applications.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119080686A_ABST
    Figure CN119080686A_ABST
Patent Text Reader

Abstract

The invention provides a fluorescent probe compound as shown in a formula (I), the fluorescent probe compound has good and stable water solubility and biocompatibility, and a complex of the fluorescent probe compound and zinc ions can recognize pyrophosphate radicals (PPI) with high selectivity and high sensitivity. The excellent properties of high selectivity, high sensitivity, visualization and the like of the fluorescent probe are fused with the characteristics of a carrier material, so that the multi-functionalization, high performance and process visualization of the fluorescent material in biological imaging application are realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of fluorescent probes, and in particular relates to a water-soluble fluorescent probe and a preparation method and application thereof. Background Art

[0002] Fluorescent molecular probes are a new method for molecular and ion detection that has emerged in recent years. They are the most popular research hotspot in supramolecular science. Fluorescent molecular probes have the characteristics of high selectivity, high sensitivity, rapidity and convenience, and can realize real-time on-site detection. Moreover, the detection process can be visualized through changes in output signals such as fluorescence, ultraviolet and color. More importantly, fluorescent molecular probes are combined with imaging technology to realize in situ imaging detection of targets in living cells or tissues, overcoming the shortcomings of traditional molecular and ion detection methods. It is a leap forward in detection technology and is widely used in the fields of molecular and ion identification, detection of bioactive substances and biological imaging, near-infrared fluorescence and time-resolved testing.

[0003] Fluorescent molecular probe molecular recognition has the advantages of high selectivity, high sensitivity, process visualization, easy implementation and strong biological applicability. However, most of the current fluorescent probe materials contain organic molecules of dyes, which have poor water solubility, poor biocompatibility, high biological toxicity and unsatisfactory detection effects. Summary of the invention

[0004] In order to solve the above problems, the present invention provides a water-soluble fluorescent probe, and a preparation method and application thereof.

[0005] The present invention provides a water-soluble fluorescent probe compound represented by formula (I):

[0006]

[0007] Wherein, R1 is selected from the following groups:

[0008] R2 is selected from hydrogen, halogen, C1-6 alkyl;

[0009] R3 is selected from C1-10 alkyl;

[0010] R4 is selected from hydrogen, C1-6 alkyl, C1-6 alkoxy;

[0011] A is selected from C6-20 aryl, 5-20 membered heteroaryl, optionally substituted by one, two or more R5;

[0012] R5 are the same or different and are independently selected from hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy;

[0013] Indicates the attachment site of the group;

[0014] m are the same or different and are independently selected from 0, 1, 2, 3;

[0015] n is the same or different and is independently selected from 0, 1, 2, 3, 4.

[0016] According to an embodiment of the present invention, A is selected from C6-14 aryl, 5-14 membered heteroaryl, optionally substituted by one, two or more R5; preferably, A is selected from C6-10 aryl, 5-10 membered heteroaryl, optionally substituted by one, two or more R5; illustratively, A is selected from phenyl, thienyl, naphthyl, optionally substituted by one, two or more R5.

[0017] According to an embodiment of the present invention, R5 is the same or different and is independently selected from hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy; preferably, R5 is selected from hydrogen, halogen, methyl, ethyl, propyl, methoxy, ethoxy, etc.; illustratively, R5 is selected from halogen, hydrogen.

[0018] According to an embodiment of the present invention, R1 is selected from the following groups: s is selected from 0, 1, 2, 3, 4, 5, 6; preferably, R1 is selected from the following groups: Exemplarily, R1 is selected from the following groups:

[0019] According to an embodiment of the present invention, R4 is selected from hydrogen, C1-3 alkyl, C1-3 alkoxy; preferably, R4 is selected from hydrogen, methyl, ethyl, propyl, methoxy, ethoxy; illustratively, R4 is selected from methyl.

[0020] According to an embodiment of the present invention, R2 is selected from hydrogen, halogen, C1-3 alkyl; preferably, R2 is selected from hydrogen, halogen, methyl, ethyl, propyl, etc.; illustratively, R2 is selected from hydrogen.

[0021] According to an embodiment of the present invention, R3 is selected from C1-6 alkyl; preferably, R3 is selected from C1-4 alkyl; illustratively, R3 is selected from methyl, ethyl, propyl, isopropyl, butyl, isobutyl, tert-butyl, etc.

[0022] According to an embodiment of the present invention, the water-soluble fluorescent probe compound has the following structure:

[0023]

[0024] The present invention also provides a compound represented by formula (II):

[0025]

[0026] Wherein, R1, R2, R3, and m have the definitions of the above formula (I);

[0027] X is selected from halogen.

[0028] The present invention also provides a method for preparing the water-soluble fluorescent probe compound represented by the above formula (I), the preparation method comprising the following steps:

[0029] The compound represented by formula (I-1) reacts with the compound represented by formula (I-2) to obtain the water-soluble fluorescent probe compound represented by formula (I);

[0030] The reaction formula is as follows:

[0031]

[0032] Wherein, R1, R2, R3, R4, R5, and m have the above definitions;

[0033] X is selected from halogen;

[0034] R0 is selected from hydrogen and methyl.

[0035] According to an embodiment of the present invention, the reaction is carried out in a solvent; preferably, the solvent is selected from toluene, tetrahydrofuran, dioxane and the like.

[0036] According to an embodiment of the present invention, the reaction is carried out in the presence of a base; preferably, the base is selected from potassium carbonate, cesium carbonate, sodium carbonate, lithium carbonate and the like.

[0037] According to an embodiment of the present invention, the reaction is carried out in the presence of a catalyst; preferably, the catalyst is selected from Pd(PPh3)4.

[0038] The present invention also provides a method for preparing the compound represented by the above formula (II), the preparation method comprising the following steps:

[0039] The compound represented by formula (I) is reacted with halogenated zinc to obtain the compound represented by formula (II).

[0040] According to an embodiment of the present invention, the halogenated zinc is selected from zinc chloride.

[0041] The present invention also provides the use of the compound represented by the above formula (I) and the compound represented by the above formula (II) in the preparation of a fluorescent probe for detecting, identifying and tracing pyrophosphate ions.

[0042] The present invention also provides the use of the compound represented by the above formula (I) and the compound represented by the above formula (II) in detecting, identifying and tracing pyrophosphate ions.

[0043] The present invention also provides the use of the compound represented by the above formula (I) and the compound represented by the above formula (II) in the preparation of products or reagents for detecting, identifying and tracing pyrophosphate ions.

[0044] According to an embodiment of the present invention, the application is non-disease diagnosis and treatment, such as targeting water environment systems.

[0045] Beneficial Effects

[0046] The present invention provides a fluorescent probe compound shown in formula (I), which has good and stable water solubility and biocompatibility, and the complex with zinc ions can identify pyrophosphate (PPI) with high selectivity and high sensitivity. The excellent properties of the fluorescent probe, such as high selectivity, high sensitivity, and visualization, are integrated with the characteristics of the carrier material to achieve multifunctionalization, high performance, and process visualization of fluorescent materials in biological imaging applications.

[0047] The term "halogen" or "halo" refers to fluorine (F), chlorine (Cl), bromine (Br) or iodine (I).

[0048] In general, the term "substituted" means that one or more hydrogen atoms in a given structure are replaced by a specific substituent. Further, when the group is substituted by more than one of the substituents, the substituents are independent of each other, that is, the more than one substituents may be different or the same. Unless otherwise indicated, a substituent group may be substituted at each substitutable position of the substituted group. When more than one position in the given structural formula can be substituted by one or more substituents selected from a specific group, the substituents may be substituted at each position in the same or different manner.

[0049] The term "C1-10 alkyl" refers to a straight or branched saturated monovalent hydrocarbon group having 1 to 10 carbon atoms. For example, "C1-6 alkyl" refers to a straight or branched alkyl group having 1, 2, 3, 4, 5 or 6 carbon atoms. Wherein, the alkyl group may be optionally substituted with one or more substituents described herein. In some embodiments, the alkyl group contains 1-10 carbon atoms; in other embodiments, the alkyl group contains 1-6 carbon atoms; in yet other embodiments, the alkyl group contains 1-4 carbon atoms. Examples of the alkyl group include, but are not limited to, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl, or the like or isomers thereof.

[0050] The term "C6-20 aryl" is understood to mean a monovalent aromatic or partially aromatic monocyclic, bicyclic or tricyclic hydrocarbon ring having 6 to 20 carbon atoms, preferably a "C6-14 aryl". The term "C6-14 aryl" is to be understood as preferably meaning a monovalent aromatic or partially aromatic monocyclic, bicyclic or tricyclic hydrocarbon ring ("C6-14 aryl") having 6, 7, 8, 9, 10, 11, 12, 13 or 14 carbon atoms, in particular a ring having 6 carbon atoms ("C6 aryl"), such as phenyl or biphenyl, or a ring having 9 carbon atoms ("C9 aryl"), such as indanyl or indenyl, or a ring having 10 carbon atoms ("C10 aryl"), such as tetrahydronaphthyl, dihydronaphthyl or naphthyl, or a ring having 13 carbon atoms ("C13 aryl"), such as fluorenyl, or a ring having 14 carbon atoms ("C14 aryl"), such as anthracenyl. When the C6-20 aryl is substituted, it may be monosubstituted or polysubstituted. Furthermore, there is no limitation on the substitution site, and for example, substitution may be at the ortho, para or meta position.

[0051] The term "5-20 membered heteroaryl" is understood to include monovalent monocyclic, bicyclic or tricyclic aromatic ring systems, including aromatic or partially aromatic ones, having 5 to 20 ring atoms and containing 1 to 5 heteroatoms independently selected from N, O and S, for example "5-14 membered heteroaryl". The term "5-14 membered heteroaryl" is understood to include monovalent monocyclic, bicyclic or tricyclic aromatic ring systems: having 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 ring atoms, in particular 5 or 6 or 9 or 10 carbon atoms, and containing 1 to 5, preferably 1 to 3 heteroatoms each independently selected from N, O and S and, in addition, in each case may be benzo-fused. In particular, the heteroaryl group is selected from thienyl, furanyl, pyrrolyl, oxazolyl, thiazolyl, imidazolyl, pyrazolyl, isoxazolyl, isothiazolyl, oxadiazolyl, triazolyl, thiadiazolyl, thiazolopyrazolyl and the like and benzo derivatives thereof, such as benzofuranyl, benzothienyl, benzoxazolyl, benzisoxazolyl, benzimidazolyl, benzotriazolyl, indazolyl, indolyl, isoindolyl and the like; or pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, triazinyl and the like and benzo derivatives thereof, such as quinolyl, quinazolinyl, isoquinolyl and the like; or azinyl, indolizinyl, purinyl and the like and benzo derivatives thereof; or cinnolinyl, phthalazinyl, quinazolinyl, quinoxalinyl, naphthyridinyl, pteridinyl, carbazolyl, acridinyl, phenazinyl, phenothiazinyl, phenoxazinyl and the like. When the 5-20 membered heteroaryl is connected to other groups to form the compound of the present invention, the carbon atom on the 5-20 membered heteroaryl ring may be connected to other groups, or the heteroatom on the 5-20 membered heteroaryl ring may be connected to other groups. When the 5-20 membered heteroaryl is substituted, it may be monosubstituted or polysubstituted. In addition, there is no limitation on the substitution site, for example, the hydrogen connected to the carbon atom on the heteroaryl ring may be substituted, or the hydrogen connected to the heteroatom on the heteroaryl ring may be substituted.

[0052] Unless otherwise specified, heterocyclic groups, heteroaryls or heteroarylene groups include all possible isomeric forms thereof, such as positional isomers thereof. Thus, for some illustrative non-limiting examples, forms substituted or bonded to other groups at one, two or more positions of the 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, 10-, 11-, 12-positions, etc. (if present), may include pyridin-2-yl, pyridin-2-ylene, pyridin-3-yl, pyridin-3-ylene, pyridin-4-ylene and pyridin-4-ylene; thienyl or thienylene groups include thien-2-yl, thien-2-ylene, thien-3-ylene and thien-3-ylene; pyrazol-1-yl, pyrazol-3-yl, pyrazol-4-yl, pyrazol-5-yl. BRIEF DESCRIPTION OF THE DRAWINGS

[0053] Figure 1This is the synthetic reaction formula of water-soluble fluorescent probe material L-1.

[0054] Figure 2 The fluorescence intensity and color of solutions No. 1 to No. 6 in Example 4 are shown in Figure 4; from left to right, they are No. 1, No. 2, No. 3, No. 4, No. 5, and No. 6.

[0055] Figure 3 This is the fluorescence intensity curve of ZnCl2-L-1 and quantitative PPi in Example 1. DETAILED DESCRIPTION

[0056] The preparation method of the present invention will be further described in detail below in conjunction with specific examples. It should be understood that the following examples are only exemplary illustrations and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are covered within the scope of protection that the present invention is intended to protect. The experimental methods used in the following examples are conventional methods unless otherwise specified; the reagents, materials, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.

[0057] Example 1 Synthesis of Compound L-1 and ZnCl2-L-1

[0058] 1.1 Synthesis of 4-bromo-2-methylpyridine-1-oxide

[0059]

[0060] 17.2 g (0.1 mol) of 4-bromo-2-methylpyridine, 20.75 g (0.12 mol) of m-chloroperbenzoic acid, and 120 mL of dichloromethane were added to a 250 mL round-bottom flask, stirred and reacted at room temperature for 9 hours, filtered, and the filtrate was evaporated to remove dichloromethane to obtain a crude product; the crude product was separated by column chromatography (ethyl acetate: methanol = 10: 1) to obtain 18.65 g of colorless oily liquid (4-bromo-2-methylpyridine-1-oxide), and the yield was 99.2%.

[0061] The characterization parameters of 4-bromo-2-methylpyridine-1-oxide are as follows: IR (KBr pellet, cm -1 ):3396.64,3028.24,1604.77,1541.12,1450.47,1394.53,1375.25,1240.23,1219.01,1199.72,1114.86,1103.28,1037.7,993.34,869.9,815.89,785.03,628.79,590.22,572.86,563.21,514.99,476.42; 1H NMR (400MHz, CDCl3) δ (ppm): 8.12 (d, 1H), 7.43 (d, 1H), 7.28-7.30 (m, 1H), 2.50 (s, 3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 150.32, 140.02, 129.37, 126.82, 118.54, 17.70.

[0062] 1.2 Synthesis of methyl 4-bromopyridine-2-acetate

[0063]

[0064] 18.8 g (0.1 mol) of 4-bromo-2-methylpyridine-1-oxide and 99.8 mL (51.7 mmol) of acetic anhydride were added to a 250 mL round-bottom flask, heated to 140 ° C for reaction for 7 hours, cooled naturally to room temperature, and then ammonia water was added to adjust the pH to neutral. The mixture was extracted three times with chloroform (50 mL*3), and the organic phase was washed with water twice, dried over anhydrous magnesium sulfate for 24 hours, filtered, and the solvent was removed by rotary evaporation to obtain a black crude product, which was vacuum dried at 65 ° C for 10 hours. Column chromatography was performed with petroleum ether: ethyl acetate = 3:1 as the mobile phase and silica gel as the stationary phase to obtain 20.26 g of a light yellow liquid product (4-bromopyridine-2-acetic acid methyl ester) with a yield of 88.05%.

[0065] The characterization parameters of 4-bromopyridine-2-acetic acid methyl ester are as follows: FT-IR (KBr pellet, cm -1 ):3051.39,2931.8,1743.65,1571.99,1556.55,1467.83,1436.97,1373.32,1222.87,1091.71,1047.35,862.18,823.6,684.73,584.43,569,555.5,538.14,484.13; 1 H NMR (400MHz, CDCl3) δ (ppm): 8.40 (d, 1H), 7.53 (d, 1H), 7.40 (m, 1H), 5.20 (s, 2H), 2.18 (s, 3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 170.39, 157.36, 150.14, 133.52, 126.17, 124.94, 65.98, 20.83.

[0066] 1.3 Synthesis of 2-hydroxymethyl-4-bromopyridine

[0067]

[0068] 11.5 g (0.05 mol) of methyl 4-bromopyridine-2-acetate, 65 mL of water, 200 mL of THF and 3.87 g (0.069 mol) of potassium hydroxide were added to a 500 mL round-bottom flask, and the mixture was stirred at room temperature for 2 hours. The solvent and water were removed by rotary evaporation to obtain a light yellow crude product, which was vacuum dried at 65° C. for 10 hours. Column chromatography was performed using petroleum ether:ethyl acetate = 3:1 as the mobile phase and silica gel as the stationary phase to obtain 9.16 g of a light yellow liquid product (2-hydroxymethyl-4-bromopyridine) with a yield of 97.45%.

[0069] The characterization parameters of 2-hydroxymethyl-4-bromopyridine are as follows: 1 H NMR (400MHz, CDCl3) δ (ppm): 8.26 (d, 1H), 7.46 (d, 1H), 7.29 (m, 1H), 4.66 (s, 2H), 3.59 (s, 1H); 13 C NMR (100MHz, CDCl3) δ (ppm): 161.32, 149.33, 133.74, 125.77, 124.13, 64.03.

[0070] 1.4 Synthesis of 2-bromomethyl-4-bromopyridine

[0071]

[0072] 1.88 g (0.01 mol) of 2-hydroxymethyl-4-bromopyridine, 96 mL of dichloromethane and 3.1 g (0.012 mol) of phosphorus tribromide were added to a 250 mL round-bottom flask, stirred at room temperature for 8 hours, and then ammonia water was added to adjust the pH to weak alkalinity. The mixture was filtered and ammonium bromide was removed. The filtrate was separated, and the aqueous phase was extracted three times with dichloromethane (50 mL x 3). The organic phase was dried over anhydrous magnesium sulfate for 24 hours, filtered, and the solvent was removed by rotary evaporation to obtain an oily liquid product, and 2.32 g of a light yellow liquid product (2-bromomethyl-4-bromopyridine) was obtained with a yield of 92.47%.

[0073] The characterization parameters of 2-bromomethyl-4-bromopyridine are as follows: 1 H NMR (400MHz, CDCl3) δ (ppm): 8.29 (d, 1H), 7.53 (s, 1H), 7.29 (d, 1H), 4.41 (s, 2H); 13 C NMR (100MHz, CDCl3) δ (ppm): 157.93, 150.01, 133.39, 126.64, 126.17, 32.46.

[0074] Synthesis of 1.5N,N-bis(4-bromopyridine-2-methyl)-n-propylamine

[0075]

[0076] 2.01 g of 2-bromomethyl-4-bromopyridine (8 mmol), 45 mL of acetonitrile, 0.21 g of n-propylamine (3.55 mmol), 2.2 g of potassium carbonate (16 mmol) and 0.1 g of potassium iodide were added to a 250 mL round-bottom flask, stirred at room temperature for 1 hour, heated to 70°C for 7 hours, cooled naturally to room temperature and filtered to remove the salt generated by the reaction, the filtrate was evaporated to remove the solvent, and column chromatography was performed with ethyl acetate as the eluent to obtain 1.31 g of a brown liquid product (N,N-di(4-bromopyridine-2-methyl)-n-propylamine) with a yield of 92.46%.

[0077] The characterization parameters of N,N-di(4-bromopyridine-2-methyl)-n-propylamine are as follows: 1 H NMR (400MHz, CDCl3) δ (ppm): 8.33 (d, 2H), 7.70 (d, 2H), 7.31-7.33 (m, 2H), 3.80 (s, 4H), 2.51-2.55 (m, 2H), 1.53-1.59 (m, 2H), 0.87-0.91 (t, 3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 161.53, 149.70, 133.41, 126.22, 125.42, 60.10, 56.80, 20.24, 11.80.

[0078] 1.6 Synthesis of N,N-bis[4-(4′-dimethylaminophenyl)-pyridine-2-methyl]-n-propylamine (L-1)

[0079]

[0080] Under argon protection, 0.3991 g of N, N-di(4-bromopyridine-2-methyl)-n-propylamine (1 mmol), 0.382 g of 4-(N, N-dimethylamino)phenylboronic acid ethylene glycol ester (2 mmol), Pd(PPh3)4 (54 mg, 46.8 μmol), 20 mL of anhydrous toluene and 20 mL of 2M potassium carbonate solution were added to a 100 mL two-necked bottle, heated to 85-90 ° C in the dark, and stirred for 48 hours. After cooling to room temperature naturally, chloroform extraction, saturated brine washing, and anhydrous magnesium sulfate drying overnight. The desiccant was filtered off at normal pressure, the solvent was vortexed, and 0.4256 g of product (L-1) was separated by column chromatography with a yield of 88.72%.

[0081] The characterization parameters of L-1 are as follows: melting point: 212-215℃; FT-IR (KBr pellet, cm -1 ):2962.66,2927.94,2889.37,2814.14,2785.21,1598.99,1560.41,1529.55,1490.97,1446.61,1361.74,1313.52,1234.44,1211.3,1174.65,1136.07,1068.56,1053.13,995.27,979.84,947.05,808.17,694.37,561.29; 1 H NMR (400MHz, CDCl3) δ (ppm): 8.45-8.46 (d, 2H), 7.89 (s, 2H), 7.56-7.58 (d, 4H), 7.30-7.32 (d, 2H), 6. 70-6.72(d,4H),3.88(s,4H),2.99(s,12H),2.62-2.65(t,2H),1.58-1.64(m,2H),0.89-0.92(t,3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 160.61, 150.94, 149.15, 148.38, 127.71, 125.52, 119.22, 118.59, 112.46, 60.68, 56.93, 40.28, 20.47, 11.99.

[0082] 1.7 Synthesis of ZnCl2-L-1

[0083]

[0084] Add 0.065 g (0.47 mmol) of anhydrous zinc chloride and 13 mL of methanol into a 50 mL round-bottom flask and stir to dissolve; dissolve 0.1918 g (0.4 mmol) of L-1 in 8 mL of dichloromethane and slowly add dropwise to the round-bottom flask. Heat at 50 ° C for 3 h, cool naturally to room temperature and filter. Wash the filter cake with 10 mL of methanol and vacuum dry at 65 ° C for 10 hours to obtain 0.22 g of a light yellow solid with a yield of 89.29% (ZnCl2-L-1).

[0085] The characterization parameters of ZnCl2-L-1 are as follows: melting point: 303-305℃; FT-IR (KBr pellet, cm -1):3441.01,2960.73,1598.99,1558.48,1541.12,1533.41,1489.05,1436.97,1363.67,1305.81,1290.38,1207.44,1168.86,1053.13,1014.56,945.12,817.82,563.21; 1 H NMR(400MHz,DMSO-d6)δ(ppm):8.78-8.80(d,2H),7.80-7.89(m,8H),6.83-6.85(d, 4H),4.13(s,4H),3.01(s,12H),2.50-2.57(m,2H),1.38(s,2H),0.66-0.70(t,3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 155.14, 151.61, 150.49, 148.00, 127.95, 121.47, 119.35, 118.57, 112.07, 56.53, 56.21, 40.01, 16.93, 11.46.

[0086] Example 2 Synthesis of Compound L-2

[0087]

[0088] Under argon protection, 0.3991 g of N, N-di(4-bromopyridine-2-methyl)-n-propylamine (1 mmol), 0.6405 g of 9, 9-dimethylfluorene-2-boronic acid pinacol ester (2 mmol), Pd(PPh3)4 (54 mg, 46.8 μmol), 20 mL of anhydrous toluene and 20 mL of 2M potassium carbonate solution were added to a 100 mL two-necked bottle, heated to 85-90 ° C in the dark, and stirred for 48 hours. After cooling to room temperature naturally, chloroform extraction, saturated brine washing, and anhydrous magnesium sulfate drying overnight. The desiccant was filtered off at normal pressure, and the solvent was vortexed; 0.5895 g of product (L-2) was obtained by column chromatography, and the yield was 94.2%.

[0089] The characterization parameters of L-2 are as follows: melting point: 79.1-80.3 °C; 1H NMR(400MHz, CDCl3)δ(ppm):8.56-8.57(d,2H),7.94(s,2H),7.66(s,2H),7.58-7.60(d,2H),7.54-7.56(d,4H),7.41 -7.43(d,4H),7.31-7.34(t,4H),3.95(s,4H),2.68-2.72(t,2H),1.65-1.70(m,2H),1.46(s,12H),0.96-1.00(t,3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 160.96, 154.46, 153.96, 149.40, 149.04, 140.15, 138.35, 137.40, 127.74, 127.18, 126.15, 122.70, 121.22, 120.68, 120.58, 120.34, 119.88, 60.68, 57.09, 46.99, 27.12, 20.46, 12.07; FT-IR (KBr pellet, cm -1 ):2956.87,2922.16,2864.29,2802.57,1598.99,1544.98,1469.76,1458.18,1448.54,1400.32,1388.75,1359.82,1276.88,1261.45,1219.01,1082.07,1066.84,887.26,825.53,783.1,759.95,736.81,700.16,570.93,449.41.

[0090] Example 3 Synthesis of Compound L-3

[0091]

[0092] Under argon protection, 0.3991 g of N, N-di(4-bromopyridine-2-methyl)-n-propylamine (1 mmol), 0.5944 g of 4-(N, N-dimethylamino)naphthalene-1-boronic acid pinacol ester (2 mmol), Pd(PPh3)4 (54 mg, 46.8 μmol), 20 mL of toluene and 20 ml of 2M potassium carbonate solution were added to a 100 mL two-necked bottle, heated to 85-90 ° C in the dark, and stirred for 36 hours. After cooling to room temperature naturally, chloroform extraction, saturated brine washing, and anhydrous magnesium sulfate drying overnight. The desiccant was filtered off at normal pressure, and the solvent was removed by rotation; 0.5436 g of oily liquid product (L-3) was obtained by column chromatography, and the yield was 93.76%.

[0093] The characterization parameters of L-3 are as follows:1 H NMR(400MHz, CDCl3)δ(ppm):8.47-8.48(d,2H),8.14-8.16(d,2H),7.64-7.66(d,2H),7.61(s,2H),7.25-7.29(t,2H),7.13-7.14( t,2H),7.04-7.08(t,4H),6.82-6.84(d,2H),3.87(s,4H),2.78(s,12H),2.51-2.55(t,2H),1.45-1.51(m,2H),0.74-0.78(t,3H); 13 C NMR (100MHz, CDCl3) δ (ppm): 160.36, 151.37, 149.39, 148.81, 132.22, 131.97, 128.80, 127.01 ,126.27,125.59,125.24,124.64,124.02,123.49,113.41,60.74,56.90,45.16,20.53,12.01.

[0094] The water solubility of the fluorescent probe materials synthesized in Example 1, Example 2 and Example 3 is shown in Table 1.

[0095] Table 1 Water solubility of fluorescent probe materials

[0096]

[0097] Example 4 Application of fluorescent probe materials

[0098] Fluorescent recognition detection of PPi by fluorescent probe materials: At room temperature, prepare a DMSO solution of L-1 (10 mmol / L) and a solution of L-1 and zinc chloride complex ZnCl2-L-1 (10 mmol / L, DMSO as solvent).

[0099] No. 1: 1 mL of HEPES solution (10 mmol / L, pH=7.4), add 10 microliters of L-1 DMSO solution (10 mmol / L).

[0100] No. 2: To 1 mL of HEPES solution (10 mmol / L, pH=7.4), add 10 microliters of ZnCl2-L-1 DMSO solution (10 mmol / L).

[0101] No. 3: To 1 mL of HEPES solution (10 mmol / L, pH=7.4), add 10 microliters of ZnCl2-L-1 DMSO solution (10 mmol / L), and then add 10 microliters of sodium pyrophosphate aqueous solution (10 mmol / L).

[0102] No. 4: 1 mL of HEPES solution (10 mmol / L, pH = 7.4), add 10 microliters of ZnCl2-L-1 DMSO solution (10 mmol / L), and then add 10 microliters of sodium dihydrogen phosphate aqueous solution (10 mmol / L).

[0103] No. 5: To 1 mL of HEPES solution (10 mmol / L, pH=7.4), add 10 microliters of ZnCl2-L-1 DMSO solution (10 mmol / L), and then add 10 microliters of ammonium dihydrogen phosphate aqueous solution (10 mmol / L).

[0104] No. 6: 1 mL of HEPES solution (10 mmol / L, pH = 7.4), add 10 microliters of ZnCl2-L-1 DMSO solution (10 mmol / L), and then add 10 microliters of sodium phosphate aqueous solution (10 mmol / L).

[0105] The fluorescence changes of solutions 1-6 were observed under 365nm ultraviolet light.

[0106] The results showed that Figure 2 As shown, only the addition of pyrophosphate ions (No. 3) can cause a significant change in the fluorescence of the probe and a decrease in the fluorescence intensity, while the addition of hydrogen phosphate ions (No. 4), dihydrogen phosphate ions (No. 5), and phosphate ions (No. 6) cannot change the fluorescence color of the probe material.

[0107] The same experimental method was used to test F - , Cl - 、NO3 - ,AcO - 、SO4 2- 、CO3 2- Effect of anions on the fluorescence intensity of fluorescent probes. The fluorescence changes of each solution were observed under 365nm ultraviolet light. The results showed that the addition of fluoride ions, chloride ions, nitrate ions, acetate ions, sulfate ions and carbonate ions did not change the fluorescence color of the probe material.

[0108] At room temperature, a solution of L-1 and zinc chloride complex ZnCl2-L-1 (10 mmol / L, DMSO as solvent) was prepared and its fluorescence intensity curve was detected; PPi (2×10 -6 mol / L), and then the fluorescence intensity curve was detected. Figure 3 shown.

[0109] The above is an explanation of the embodiments of the present invention. However, the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A water-soluble fluorescent probe compound represented by formula (I): in, R1 is selected from the following groups: R2 is selected from hydrogen, halogen, C1-6 alkyl; R3 is selected from C1-10 alkyl; R4 is selected from hydrogen, C1-6 alkyl, C1-6 alkoxy; A is selected from C6-20 aryl, 5-20 membered heteroaryl, optionally substituted by one, two or more R5; R5 are the same or different and are independently selected from hydrogen, halogen, C1-6 alkyl, C1-6 alkoxy; Indicates the attachment site of the group; m are the same or different and are independently selected from 0, 1, 2, 3; n is the same or different and is independently selected from 0, 1, 2, 3, 4.

2. The water-soluble fluorescent probe compound according to claim 1, characterized in that A is selected from C6-14 aryl, 5-14 membered heteroaryl, optionally substituted by one, two or more R5; Preferably, R5 are the same or different and are independently selected from hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy; Preferably, R1 is selected from the following groups: s is selected from 0, 1, 2, 3, 4, 5, 6; Preferably, R4 is selected from hydrogen, C1-3 alkyl, C1-3 alkoxy; Preferably, R2 is selected from hydrogen, halogen, C1-3 alkyl; Preferably, R3 is selected from C1-6 alkyl.

3. The water-soluble fluorescent probe compound according to claim 1 or 2, characterized in that: The water-soluble fluorescent probe compound has the following structure:

4. The compound represented by formula (II): in, R1, R2, R3, and m have the meanings as defined in any one of claims 1 to 3; X is selected from halogen.

5. A method for preparing a water-soluble fluorescent probe compound represented by formula (I) according to any one of claims 1 to 3, the method comprising the following steps: The compound represented by formula (I-1) reacts with the compound represented by formula (I-2) to obtain the water-soluble fluorescent probe compound represented by formula (I); The reaction formula is as follows: in, R1, R2, R3, R4, R5, and m have the meanings as defined in any one of claims 1 to 3; X is selected from halogen; R0 is selected from hydrogen and methyl.

6. A method for preparing the compound of formula (II) according to claim 4, comprising the following steps: The compound represented by formula (I) is reacted with halogenated zinc to obtain the compound represented by formula (II).

7. Use of the compound of formula (I) according to any one of claims 1 to 3 and the compound of formula (II) according to claim 4 in the preparation of a fluorescent probe for detecting, identifying and tracing pyrophosphate ions.

8. Use of the compound of formula (I) according to any one of claims 1 to 3 and the compound of formula (II) according to claim 4 in detecting, identifying and tracing pyrophosphate ions.

9. Use of the compound of formula (I) according to any one of claims 1 to 3 or the compound of formula (II) according to claim 4 in the preparation of a product or reagent for detecting, identifying or tracing pyrophosphate ions.

10. The use according to any one of claims 7 to 9, characterized in that: The applications are non-disease diagnosis and treatment, for example for water environment systems.